Cargando…
Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599877/ http://dx.doi.org/10.1186/1546-0096-13-S1-P166 |
| _version_ | 1782394335977799680 |
|---|---|
| author | Ishigatsubo, Y Takeno, M Kirino, Y Mizuki, N |
| author_facet | Ishigatsubo, Y Takeno, M Kirino, Y Mizuki, N |
| author_sort | Ishigatsubo, Y |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4599877 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45998772015-10-13 Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis Ishigatsubo, Y Takeno, M Kirino, Y Mizuki, N Pediatr Rheumatol Online J Poster Presentation BioMed Central 2015-09-28 /pmc/articles/PMC4599877/ http://dx.doi.org/10.1186/1546-0096-13-S1-P166 Text en Copyright © 2015 Ishigatsubo et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Ishigatsubo, Y Takeno, M Kirino, Y Mizuki, N Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis |
| title | Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis |
| title_full | Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis |
| title_fullStr | Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis |
| title_full_unstemmed | Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis |
| title_short | Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis |
| title_sort | development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in behçet's disease with uveitis |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599877/ http://dx.doi.org/10.1186/1546-0096-13-S1-P166 |
| work_keys_str_mv | AT ishigatsuboy developmentofantiinfliximabantibodyisassociatedwithreducedefficacyandinfusionreactioninbehcetsdiseasewithuveitis AT takenom developmentofantiinfliximabantibodyisassociatedwithreducedefficacyandinfusionreactioninbehcetsdiseasewithuveitis AT kirinoy developmentofantiinfliximabantibodyisassociatedwithreducedefficacyandinfusionreactioninbehcetsdiseasewithuveitis AT mizukin developmentofantiinfliximabantibodyisassociatedwithreducedefficacyandinfusionreactioninbehcetsdiseasewithuveitis |